Replies to post #601656 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

It is time for NWBO to get this approved because they cannot limp along endlessly hoping as you put it that manufacturing can be automated before MAA submission.

Basically NWBO investors were told they were waiting on the development of one technology - DCVax-L and then they are told and not really by the company directly but by surrogates, they have to also waited on another technology - automation - before they receive their reward.

While automating sounds good, rolling out a new technology NWBO grabbed out of the bargain basement bin is not something NWBO can do quickly or cheaply and what they saved on the front end by buying a fixer-upper they now have to pay back in time , not just money, to make it work.

[Doc logic]

beachhyena,

It would be more humane to have had access since 2012. The status quo could care less about providing a safe treatment with obvious signal of effect to patients on a more limited basis. NWBO was faced with treating fewer patients early and many more later or many more just a little bit later than an earlier approval would be granted. Best wishes.